Log in to search using one of your social media accounts:


New Ray of Hope on Cancer Therapy Through Global Conference Series...

2017 Oncology conference series schedule released(PRWeb September 26, 2016)Read the full story at http://www.prweb.com/releases/conferences-series-annual/meetings-2017/prweb13713036.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news

Related Links:

Authors: Rai SK Abstract Many infectious/communicable diseases (IDs) are endemic in Nepal. Until a decade and half ago, IDs were the major cause of both morbidity and mortality accounting 70% for both. However, as a result of various preventive measures implemented by both the state and non-state actors, the overall IDs have shown a changing (declining) trend. The most impressive decline has been seen in the intestinal helminth infection. Though the overall burden of IDs is decreasing, several newer infectious diseases (emerging infections) namely, dengue fever, scrub typhus, influenza (H5N1 and H1N1), and others a...
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
RenovoRx said today that it closed a $7 million tranche in a $10 million round to fund the development of its drug-device combination product designed to deliver chemotherapy directly to tumors in patients with locally advanced pancreatic cancer. The company’s round was led by Boston Scientific (NYSE:BSX) and joined by btov Partners, Astia Angels, Golden Seeds and others. Get the full story at our sister site, Drug Delivery Business News. The post RenovoRx raises $7m for drug-device pancreatic cancer therapy appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Drug-Device Combinations Food & Drug Administration (FDA) Funding Roundup Oncology Pharmaceuticals Regulatory/Compliance Vascular RenovoRx Source Type: news
Publication date: Available online 22 May 2018 Source:Acta Pharmaceutica Sinica B Author(s): Xiao-Mei Qi, Fang Wang, Matthew Mortensen, Ryan Wertz, Guan Chen Protein kinases and phosphatases signal by phosphorylation and dephosphorylation to precisely control the activities of their individual and common substrates for a coordinated cellular outcome. In many situations, a kinase/phosphatase complex signals dynamically in time and space through their reciprocal regulations and their cooperative actions on a substrate. This complex may be essential for malignant transformation and progression and can therefore be considered...
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research
Nanomedicine, Ahead of Print.
Source: Future Medicine: Nanomedicine - Category: Nanotechnology Authors: Source Type: research
Publication date: 1 September 2018 Source:Colloids and Surfaces B: Biointerfaces, Volume 169 Author(s): Yalei Miao, Yudian Qiu, Wenjing Yang, Yuqi Guo, Hongwei Hou, Zhongyi Liu, Xubo Zhao Dual pH-/reduction-sensitive biodegradable poly(methacrylic acid-co-N,N-bis(acryloyl)cystamine)/chitosan/dimethylmaleic anhydride-modified chitosan (PMAABACy/CS/CS-DMMA) nanoparticles with PMAABACy cores as carriers and dimethylmaleic anhydride-modified chitosan as charge reversible shells were rationally designed. PMAABACy cores using N,N-Bis(acryloyl)cystamine (BACy) as a crosslinker and methacrylic acid (MAA) as a monomer were fabrica...
Source: Colloids and Surfaces B: Biointerfaces - Category: Biochemistry Source Type: research
Nanomedicine, Ahead of Print.
Source: Nanomedicine - Category: Nanotechnology Authors: Source Type: research
  Purdue University is reporting on a new method of targeting cancer cells, developed by scientists in its Nuclear Engineering department. Dubbed PLASMAT, the technique combines cold atmospheric plasma, an ionized gas that brings with it active ...
Source: Medgadget - Category: Medical Devices Authors: Tags: Surgery Source Type: blogs
Authors: Li Q, Wu J, Chen S, Zhao Y Abstract The introduction of the theory of cancer stem cells (CSCs) has provided a new direction and perspective for our understanding of the nature and origin of tumors. Cancer stem cells are believed to be responsible for the treatment failure, drug tolerance, metastasis, and recurrence of tumors. However, it remains a challenge to identify or isolate tumor stem cells and determine their regulatory mechanisms. Therefore, further understanding of the biological characteristics and functions of CSCs is of great practical significance and value to develop new methods of tumor diag...
Source: Histology and Histopathology - Category: Cytology Tags: Histol Histopathol Source Type: research
Preclinical tumor models are the foundation of translational cancer research. For exploring fundamental biologic mechanisms or designing new cancer therapies, in  vitro and in vivo models are the indispensable test environments in which countless discoveries have been made. Conventional models rely on immortalized cell lines that are notable for their reproducibility, convenience, and ease of use. Although these approaches continue to be widely used, their limitations are well known. In particular, these models are often criticized as poor reproductions of clinical tumors.
Source: Journal of Vascular and Interventional Radiology : JVIR - Category: Radiology Authors: Tags: Research in Translation Source Type: research
AbstractHyperthermia is a promising alternative modality for the conventional cancer treatments. Nanoparticle-mediated photothermal therapy (PTT) has been widely applied for hyperthermia cancer therapy by a near-infrared light irradiation. Some special nanoparticles can convert light energy into heat and destroy the tumor cells. Inspired from the photothermal efficacy of the gold nanoparticles, here we synthesized, characterized, and applied novel photothermal polyethylene glycol-curcumin-gold nanoparticles (PEG-Cur-Au NPs) in cancer PTT. The effect of PEG-Cur-Au NPs upon irradiation by an 808-nm laser on C540 (B16/F10) ce...
Source: Lasers in Medical Science - Category: Laser Surgery Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Conferences